ArticlePhysical activity and nutrition2026
A complementary amino acid formulation enhances exercise-induced skeletal muscle remodeling during resistance training.
Article in Physical activity and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
purposeThis study investigated whether a five-amino-acid formulation integrating complementary anabolic, metabolic, and redox-supporting functions enhances skeletal muscle remodeling during resistance training.
methodsMale C57BL/6N mice were assigned to eight groups receiving vehicle, leucine (300 mg/kg), or amino acid formulation (150-1,500 mg/kg). All mice completed four weeks of ladder resistance training, while the assigned supplements were administered orally once daily. Muscle function, body composition, gastrocnemius fiber cross-sectional area (CSA), anabolic and metabolic signaling proteins, the muscular NAD+/NADH ratio, and circulating markers of muscle damage, inflammation, and glutathione status were assessed.
resultsThe formulation improved grip strength at doses of 600-1,500 mg/kg and increased gastrocnemius fiber CSA at 1,200 and 1,500 mg/kg compared with vehicle (p < 0.05), without affecting body weight, food intake, body composition, or absolute muscle mass. It also enhanced AKT-related signaling and increased the expression of PGC-1α, citrate synthase, and UCP3. Several anabolic and mitochondrial protein responses exceeded those observed with leucine alone. The NAD+/NADH ratio increased at doses of 150, 900, and 1,200 mg/kg, with the greatest response observed at 900 mg/kg. The formulation reduced circulating TNF-α at a dose of 1,200 mg/kg, produced a dose-related decrease in CKM that approached statistical significance at 1,500 mg/kg, and most prominently increased total and reduced glutathione levels at 900 mg/kg.
conclusionThe complementary amino acid formulation enhanced functional, structural, anabolic, metabolic, and redox adaptations during resistance training. These coordinated effects support its potential as a nutritional strategy for improving skeletal muscle quality during chronic resistance exercise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.